Abstract
No public abstract is available from the verified source records.
Ludovico Cobuccio, Keyvan Moser, Damien Jacot, Alexandre Bleibtreu, Anastasios D. Tsaousis, Tatiana Galperine
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Comparison of Microscopy and PCR for Detection of Intestinal Parasites in Danish Patients Supports an Incentive for Molecular Screening Platforms
10.1128/jcm.06012-11 · 2012
Blastocystis in Health and Disease: Are We Moving from a Clinical to a Public Health Perspective?
10.1128/jcm.02520-15 · 2016
Aspects of Genetic Diversity, Host Specificity and Public Health Significance of Single-Celled Intestinal Parasites Commonly Observed in Humans and Mostly Referred to as “Non-Pathogenic.”
10.1111/apm.70036 · 2025
A protocol for mapping Blastocystis epidemiology and diagnostics from One Health perspective
10.12688/openreseurope.20151.3 · 2025
Blastocystis One Health Approach in a Rural Community of Northern Thailand: Prevalence, Subtypes and Novel Transmission Routes
10.3389/fmicb.2021.746340 · 2021
Prevalence of Intestinal Parasitic Infections among Children in Europe over the Last Five Years
10.3390/tropicalmed6030160 · 2021
Intestinal Blastocystis is linked to healthier diets and more favorable cardiometabolic outcomes in 56,989 individuals from 32 countries
10.1016/j.cell.2024.06.018 · 2024
Dientamoeba fragilis , One of the Neglected Intestinal Protozoa
10.1128/jcm.00400-16 · 2016
datacite
Confidence 0%
Dientamoeba Fragilis in the North-East of Italy: Prevalence study and treatment
10.1016/j.parint.2020.102227 · 2021
Irritable bowel syndrome: A review on the role of intestinal protozoa and the importance of their detection and diagnosis
10.1016/j.ijpara.2006.09.009 · 2007
Frequency, spatial distribution, and genetic diversity of Blastocystis among referred individuals to a clinical laboratory: First report of subtype 9 in Brazil
10.1016/j.actatropica.2022.106608 · 2022
Evaluation of microscopy and PCR for detection of Dientamoeba fragilis
10.4103/tp.tp_93_21 · 2022
Molecular epidemiology of Dientamoeba fragilis
10.1016/j.actatropica.2017.06.029 · 2018
Geographic distribution of human Blastocystis subtypes in South America
10.1016/j.meegid.2016.03.017 · 2016
The Low Genetic Diversity of Dientamoeba fragilis Isolates in Southwest Turkey and Analysis of Clinical Findings
10.1007/s11686-024-00896-x · 2024
Blastocystis Colonization Alters the Gut Microbiome and, in Some Cases, Promotes Faster Recovery From Induced Colitis
10.3389/fmicb.2021.641483 · 2021
The Prevalence of Intestinal Parasites Is Not Greater Among Individuals With Irritable Bowel Syndrome: A Population-based Case-control Study
10.1016/j.cgh.2014.07.065 · 2015
The role of Blastocystis sp. And Dientamoeba fragilis in irritable bowel syndrome: A systematic review and meta-analysis
10.1007/s00436-017-5535-6 · 2017
The neglected role of Blastocystis sp. And Giardia lamblia in development of irritable bowel syndrome: A systematic review and meta-analysis
10.1016/j.micpath.2021.105215 · 2022
No evidence of pathogenicity of Dientamoeba Fragilis following detection in stools: A case-control study
10.1051/parasite/2024041 · 2024
Metronidazole Therapy for Treating Dientamoebiasis in Children Is Not Associated With Better Clinical Outcomes: A Randomized, Double-Blinded and Placebo-Controlled Clinical Trial
10.1093/cid/ciu188 · 2014
Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial
10.1093/jtm/taac143 · 2023
No Advantage for Antibiotic Treatment Over Placebo in Blastocystis hominis–positive Children With Recurrent Abdominal Pain
10.1097/mpg.0b013e31823a29a7 · 2012
Intragenomic diversity of the small subunit rDNA gene shows limited impact on the pathogenicity of Blastocystis infection in clinical patients
10.1016/j.micinf.2024.105422 · 2025
Pathogenic mechanisms in Blastocystis spp. — Interpreting results from in vitro and in vivo studies
10.1016/j.parint.2016.05.007 · 2016
The Microbiome Within a Microbe: Rethinking Blastocystis Biology
10.1111/jeu.70056 · 2026
Infection with pathogenic Blastocystis ST7 is associated with decreased bacterial diversity and altered gut microbiome profiles in diarrheal patients
10.1186/s13071-022-05435-z · 2022
Rethinking Blastocystis : Ubiquity and cyclical abundance in the human gut
10.1016/j.pt.2025.08.009 · 2025
Multilocus sequence typing of Dientamoeba Fragilis identified a major clone with widespread geographical distribution
10.1016/j.ijpara.2016.07.002 · 2016
Prospective study of the prevalence, genotyping, and clinical relevance of Dientamoeba fragilis infections in an Australian population
10.1128/jcm.43.6.2718-2723.2005 · 2005
Cyst formation and faecal-oral transmission of Dientamoeba fragilis –the missing link in the life cycle of an emerging pathogen
10.1016/j.ijpara.2013.06.003 · 2013
Observations on the transmission of Dientamoeba fragilis and the cyst life cycle stage
10.1017/s0031182024000076 · 2024
Description of Dientamoeba fragilis cyst and precystic forms from human samples
10.1128/jcm.00813-14 · 2014
Dientamoeba fragilis: A story of contradictions
10.1099/jmm.0.002110 · 2026
Parasite load as a marker of pathogenicity in Dientamoeba fragilis infections
10.1097/md.0000000000041963 · 2025
Insights into the Association Between Blastocystis Infection and Colorectal Cancer
10.1007/s11686-025-01079-y · 2025
European consensus conference on faecal microbiota transplantation in clinical practice
10.1136/gutjnl-2016-313017 · 2017
Human Transmission of Blastocystis by Fecal Microbiota Transplantation Without Development of Gastrointestinal Symptoms in Recipients
10.1093/cid/ciz1122 · 2020
Transient colonization with Blastocystis spp. After transmission via fecal microbiota transplantation
10.1007/s10096-025-05124-6 · 2025
Assessment of Dientamoeba fragilis interhuman transmission by fecal microbiota transplantation
10.1016/j.ijantimicag.2025.107504 · 2025
Understanding the mechanisms and drivers of antimicrobial resistance
10.1016/s0140-6736(15)00473-0 · doi-reference
Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans
10.1093/jac/dky471 · doi-reference
Division of Blastocystis ST10 into three new subtypes: ST42–ST44
10.1111/jeu.12998 · doi-reference
Experimental colonization with Blastocystis ST4 is associated with protective immune responses and modulation of gut microbiome in a DSS-induced colitis mouse model
10.1007/s00018-022-04271-9 · doi-reference
Intestinal Microbiota in Children With Symptomatic Dientamoeba fragilis Infection: A Case-control Study
10.1097/inf.0000000000002975 · doi-reference
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice
10.1136/gutjnl-2019-319548 · doi-reference
Prevalence, risk factors for infection and subtype distribution of the intestinal parasite Blastocystis sp. from a large-scale multi-center study in France
10.1186/s12879-016-1776-8 · doi-reference
Evaluation of the AllplexTM Gastrointestinal Panel—Parasite Assay for Protozoa Detection in Stool Samples: A Retrospective and Prospective Study
10.3390/microorganisms8040569 · doi-reference
Dientamoeba fragilis in Denmark: epidemiological experience derived from four years of routine real-time PCR
10.1007/s10096-013-1880-2 · doi-reference
The clinical significance of Dientamoeba fragilis and Blastocystis in human stool—retrospective cohort study
10.1016/j.cmi.2023.09.003 · doi-reference
Improvement of the diagnosis of intestinal protozoa using a multiplex qPCR strategy compared to classical microscopy: a prospective study on 3,500 stool samples over 3 years
10.1128/jcm.01610-24 · doi-reference
Evaluation of the Roche LightMix Gastro parasites multiplex PCR assay detecting Giardia duodenalis, Entamoeba histolytica, cryptosporidia, Dientamoeba fragilis, and Blastocystis hominis
10.1016/j.cmi.2018.03.025 · doi-reference
Characterization of gut microbiomes in rural Honduras reveals uncharacterized species and associations with human genetic variation
10.1016/j.celrep.2025.116724 · doi-reference
Changes in the Human Gut Microbiota Associated With Colonization by Blastocystis sp. And Entamoeba spp. In Non-Industrialized Populations
10.3389/fcimb.2021.533528 · doi-reference
Gut Microbiome Profiles in Colonizations with the Enteric Protozoa Blastocystis in Korean Populations
10.3390/microorganisms10010034 · doi-reference
Characteristics of the bacterial microbiome in association with common intestinal parasites in irritable bowel syndrome
10.1038/s41424-018-0027-2 · doi-reference
Asymptomatic Intestinal Colonization with Protist Blastocystis Is Strongly Associated with Distinct Microbiome Ecological Patterns
10.1128/msystems.00007-18 · doi-reference
Large-scale comparative metagenomics of Blastocystis , a common member of the human gut microbiome
10.1038/ismej.2017.139 · doi-reference
Population-level analysis of Blastocystis subtype prevalence and variation in the human gut microbiota
10.1136/gutjnl-2018-316106 · doi-reference
Colonization with the enteric protozoa Blastocystis is associated with increased diversity of human gut bacterial microbiota
10.1038/srep25255 · doi-reference
A standardised model for stool banking for faecal microbiota transplantation: A consensus report from a multidisciplinary UEG working group
10.1177/2050640620967898 · doi-reference
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey
10.1016/j.lanepe.2021.100181 · doi-reference
Fecal Microbiota Transplantation Donor Screening: Is Dientamoeba fragilis a Valid Criterion for Donor Exclusion? A Longitudinal Study of a Swiss Cohort
10.3390/microorganisms14010217 · doi-reference